<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940606-2-00055</title>
	</head>
	<body>
		<main>
			<p><!-- PJG ITAG l=10 g=1 f=2 --> EFFECTIVE DATE: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  July 6, 1994. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> <!-- PJG STAG 4703 -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=1 -->  <USBUREAU>Food and Drug Administration</USBUREAU> <!-- PJG /ITAG -->  <!-- PJG ITAG l=52 g=1 f=1 -->  <DOCTITLE>[Docket No. 94N&hyph;0195]</DOCTITLE> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 --> Adria Laboratories, et al.; Withdrawal of Approval of 15 Abbreviated New Drug Applications <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <AGENCY> <!-- PJG ITAG l=10 g=1 f=2 --> AGENCY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Food and Drug Administration, HHS. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </AGENCY> <ACTION> <!-- PJG ITAG l=10 g=1 f=2 --> ACTION: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Notice. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG ITAG l=59 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </ACTION> <SUMMARY> <!-- PJG ITAG l=10 g=1 f=2 --> SUMMARY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  The Food and Drug Administration (FDA) is withdrawing approval of 15 abbreviated new drug applications (ANDA's). The holders of the ANDA's notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </SUMMARY> <DATE> <!-- PJG ITAG l=10 g=1 f=2 --> EFFECTIVE DATE: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  July 6, 1994. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </DATE> <FURTHER> <!-- PJG ITAG l=10 g=1 f=2 --> FOR FURTHER INFORMATION CONTACT: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->   <!-- PJG 0012 frnewline --> Lola E. Batson,  <!-- PJG 0012 frnewline --> Center for Drug Evaluation and Research (HFD&hyph;360),  <!-- PJG 0012 frnewline --> Food and Drug Administration,  <!-- PJG 0012 frnewline --> 7500 Standish Pl.,  <!-- PJG 0012 frnewline --> Rockville, MD 20855,  <!-- PJG 0012 frnewline --> 301&hyph;594&hyph;1038.  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </FURTHER> <SUPPLEM> <!-- PJG ITAG l=10 g=1 f=2 --> SUPPLEMENTARY INFORMATION: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  The holders of the ANDA's listed in the table in this document have informed FDA that these drug products are no longer marketed and have requested that FDA withdraw approval of the applications. The applicants have also, by their request, waived their opportunity for a hearing.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <TABLE>  <!-- PJG tableformat 3,L1,s20,xl70,r70  -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1ANDA no. <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Drug <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1Applicant <!-- PJG 007 0152 intable -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> 17&hyph;959 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Fluorouracil Injection, <!-- PJG 0012 frnewline --> U.S.P., 50 milligrams  <!-- PJG 0012 frnewline --> (mg)/milliliter  <!-- PJG 0012 frnewline --> (mL)  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Adria Laboratories,  <!-- PJG 0012 frnewline --> P.O. Box 16529,  <!-- PJG 0012 frnewline --> Columbus, OH 43216&hyph;6529.  <!-- PJG 0012 frnewline --> 18&hyph;419 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Furosemide Tablets, U.S.P.,  <!-- PJG 0012 frnewline -->  20 mg, 40 mg, and 80 mg  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Warner Chilcott  <!-- PJG 0012 frnewline --> Laboratories,  <!-- PJG 0012 frnewline -->  201 Tabor Rd.,  <!-- PJG 0012 frnewline -->  Morris Plain, NJ 07950.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 18&hyph;420 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Furosemide Injection, U.S.P.,  <!-- PJG 0012 frnewline --> 10 mg/mL <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable -->  <!-- PJG 007 0157 intable --> i0Do. <!-- PJG 0012 frnewline --> 18&hyph;670  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Furosemide Injection,  <!-- PJG 0012 frnewline -->  U.S.P.,  <!-- PJG 0012 frnewline -->  10 mg/mL  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Wyeth-Ayerst Laboratories,  <!-- PJG 0012 frnewline --> P.O. Box 8299,  <!-- PJG 0012 frnewline --> Philadelphia, PA 19101&hyph;1245.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 18&hyph;690 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Indomethacin Capsules,  <!-- PJG 0012 frnewline --> U.S.P.,  <!-- PJG 0012 frnewline --> 25 mg and 50 mg  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Chelsea Laboratories, Inc.,  <!-- PJG 0012 frnewline --> 896 Orlando Ave.,  <!-- PJG 0012 frnewline --> West Hempstead, NY 11552.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 19&hyph;106  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Hydrocortisone Butyrate  <!-- PJG 0012 frnewline -->  Ointment 0.1%  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Galderma Laboratories, Inc.,  <!-- PJG 0012 frnewline -->  3000 Alta Mesa Blvd.,  <!-- PJG 0012 frnewline -->  suite 300,  <!-- PJG 0012 frnewline -->  P.O. Box 331329,  <!-- PJG 0012 frnewline -->  Fort Worth, TX 76163. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 72&hyph;398 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Sulfamethoxazole and  <!-- PJG 0012 frnewline -->  Trimethoprim Oral  <!-- PJG 0012 frnewline -->  Suspension, U.S.P.,  <!-- PJG 0012 frnewline -->  200 mg/40 mg per 5 mL  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Barre-National, Inc.,  <!-- PJG 0012 frnewline --> 333 Cassell Dr.,  <!-- PJG 0012 frnewline --> suite 3500,  <!-- PJG 0012 frnewline --> Baltimore, MD 21224.  <!-- PJG 0012 frnewline --> 85&hyph;191  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Hydrocortisone Cream,  <!-- PJG 0012 frnewline -->  U.S.P., 1%  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Lemmon Co.,  <!-- PJG 0012 frnewline --> 650 Cathill Rd.,  <!-- PJG 0012 frnewline --> Sellersville, PA 18960. <!-- PJG 0012 frnewline --> 85&hyph;214 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Sterile Hydrocortisone, <!-- PJG 0012 frnewline -->  Acetate Suspension,  <!-- PJG 0012 frnewline -->  U.S.P., 50 mg/mL  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Steris Laboratories, Inc.,  <!-- PJG 0012 frnewline --> 620 North 51st Ave.,  <!-- PJG 0012 frnewline --> Phoenix, AZ 85043&hyph;4705. <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 86&hyph;001 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Theophylline Syrup,  <!-- PJG 0012 frnewline -->  80&hyph;2 mg/15 mL  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Barre-National, Inc. <!-- PJG 0012 frnewline --> 87&hyph;161 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Dipyridamole Tablets,  <!-- PJG 0012 frnewline -->  U.S.P., 75 mg <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Chelsea Laboratories, Inc. <!-- PJG 0012 frnewline --> 88&hyph;449 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Fluocinolone Acetonide, <!-- PJG 0012 frnewline -->  Topical Solution, U.S.P.,  <!-- PJG 0012 frnewline -->  0.01%  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Pharmafair, Inc.,  <!-- PJG 0012 frnewline --> 110 Kennedy Dr.,  <!-- PJG 0012 frnewline --> Hauppauge, NY 11788. <!-- PJG 0012 frnewline --> 88&hyph;475 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Glycopyrrolate Injection,  <!-- PJG 0012 frnewline --> U.S.P., 0.2 mg/mL  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Fujisawa USA, Inc.,  <!-- PJG 0012 frnewline --> Parkway North Center,  <!-- PJG 0012 frnewline --> Three Parkway North,  <!-- PJG 0012 frnewline --> Deerfield, IL 60015&hyph;2548. <!-- PJG 0012 frnewline --> 88&hyph;606 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Acetic Acid 2% and  <!-- PJG 0012 frnewline -->  Aluminum Acetate Otic Solution <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Pharmafair, Inc. <!-- PJG 0012 frnewline --> 89&hyph;223 <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Theophylline Elixir,  <!-- PJG 0012 frnewline -->  80 mg/15 mL  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Barre-National, Inc. <!-- PJG /ITAG -->  </TABLE>  <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> Therefore, under section 505(e) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(e)) and under authority delegated to the Director, Center for Drug Evaluation and Research (21 CFR 5.82), approval of the ANDA's listed above, and all amendments and supplements thereto, is hereby withdrawn, effective July 6, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: May 24, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SUPPLEM> <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Murray M. Lumpkin, <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Acting Director, Center for Drug Evaluation and Research. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;13711 Filed 6&hyph;3&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4160&hyph;01&hyph;F <!-- PJG /ITAG --> </BILLING>  <!-- PJG /STAG --></p>
		</main>
</body></html>
            